Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability

NeuroImage

Volumn 125, Issue , 2016, Pages 446-455

  Heye, Anna K ^a   Thrippleton, Michael J ^a   Armitage, Paul A ^a,b   Valdés Hernández, Maria del C ^a   Makin, Stephen D ^a   Glatz, Andreas ^a   Sakka, Eleni ^a   Wardlaw, Joanna M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Blood brain barrier; Cerebral small vessel disease; Dynamic contrast enhanced MRI; Tracer kinetic modelling

Indexed keywords

MEGLUMINE; CONTRAST MEDIUM;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEMBRANE PERMEABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL PROCESSING; SYSTEMATIC ERROR; TRACER KINETIC MODELING; VALIDITY; AGED; BRAIN MAPPING; CAPILLARY PERMEABILITY; FEMALE; IMAGE ENHANCEMENT; IMAGE PROCESSING; KINETICS; MALE; MIDDLE AGED; NEURONAVIGATION; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

AGED; BLOOD-BRAIN BARRIER; BRAIN MAPPING; CAPILLARY PERMEABILITY; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONAVIGATION; STROKE;

EID: 84946213697     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.10.018     Document Type: Article

References (59)

1. Ahearn T.S., Staff R.T., Redpath T.W., Semple S.I.K. The use of the Levenberg-Marquardt curve-fitting algorithm in pharmacokinetic modelling of DCE-MRI data. Phys. Med. Biol. 2005, 50:N85-N92. 10.1088/0031-9155/50/9/N02.
2. Akaike H. A new look at the statistical model identification. IEEE Trans. Autom. Control 1974, 19:716-723. 10.1109/TAC.1974.1100705.
3. Armitage P., Behrenbruch C., Brady M., Moore N. Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast. Med. Image Anal. 2005, 9:315-329. 10.1016/j.media.2005.01.001.
4. Armitage P.A., Farrall A.J., Carpenter T.K., Doubal F.N., Wardlaw J.M. Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. Magn. Reson. Imaging 2011, 29:305-314. 10.1016/j.mri.2010.09.002.
5. Barnes S.R., Ng T.S.C., Montagne A., Law M., Zlokovic B.V., Jacobs R.E. Optimal acquisition and modeling parameters for accurate assessment of low K trans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn. Reson. Med. 2015, 10.1002/mrm.25793.
6. Brickman A.M., Zahra A., Muraskin J., Steffener J., Holland C.M., Habeck C., Borogovac A., Ramos M.A., Brown T.R., Asllani I., Stern Y. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res. 2009, 172:117-120. 10.1016/j.pscychresns.2008.11.006.
7. Brix G., Zwick S., Kiessling F., Griebel J. Pharmacokinetic analysis of tissue microcirculation using nested models: multimodel inference and parameter identifiability. Med. Phys. 2009, 36:2923. 10.1118/1.3147145.
8. Brookes J.A., Redpath T.W., Gilbert F.J., Murray A.D., Staff R.T. Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot. J. Magn. Reson. Imaging 1999, 9:163-171.
9. Budde M.D., Gold E., Jordan E.K., Frank J.A. Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI. Clin. Exp. Metastasis 2012, 29:51-62. 10.1007/s10585-011-9428-2.
10. Burnham K.P., Anderson D.R. Multimodel inference: understanding AIC and BIC in model selection. Sociol. Methods Res. 2004, 33:261-304. 10.1177/0049124104268644.
11. Cramer S.P., Larsson H.B.W. Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. J. Cereb. Blood Flow Metab. 2014, 34:1655-1665. 10.1038/jcbfm.2014.126.
12. Cramer S.P., Simonsen H., Frederiksen J.L., Rostrup E., Larsson H.B.W. Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. NeuroImage Clin. 2014, 4:182-189. 10.1016/j.nicl.2013.12.001.
13. Deoni S.C.L. High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI). J. Magn. Reson. Imaging 2007, 26:1106-1111. 10.1002/jmri.21130.
14. Farrall A.J., Wardlaw J.M. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol. Aging 2009, 30:337-352. 10.1016/j.neurobiolaging.2007.07.015.
15. Farrell C., Chappell F., Armitage P.A., Keston P., Maclullich A., Shenkin S., Wardlaw J.M. Development and initial testing of normal reference MR images for the brain at ages 65-70 and 75-80 years. Eur. Radiol. 2009, 19:177-183. 10.1007/s00330-008-1119-2.
16. Friedman L., Glover G.H. Report on a multicenter fMRI quality assurance protocol. J. Magn. Reson. Imaging 2006, 23:827-839. 10.1002/jmri.20583.
17. Hanyu H., Asano T., Tanaka Y., Iwamoto T., Takasaki M., Abe K. Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI. Dement. Geriatr. Cogn. Disord. 2002, 14:1-6. 10.1159/000058326.
18. Heye A.K., Culling R.D., Valdés Hernández M.D.C., Thrippleton M.J., Wardlaw J.M. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. NeuroImage Clin. 2014, 6:262-274. 10.1016/j.nicl.2014.09.002.
19. Homer J., Beevers M.S. Driven-equilibrium single-pulse observation of T1 relaxation. A reevaluation of a rapid "new" method for determining NMR spin-lattice relaxation times. J. Magn. Reson. 1985, 63:287-297. 10.1016/0022-2364(85)90318-X.
20. Huisa B.N., Caprihan A., Thompson J., Prestopnik J., Qualls C.R., Rosenberg G.A. Long-term blood-brain barrier permeability changes in Binswanger disease. Stroke 2015, 46:2413-2418. 10.1161/STROKEAHA.115.009589.
21. Iadecola C. The pathobiology of vascular dementia. Neuron 2013, 80:844-866. 10.1016/j.neuron.2013.10.008.
22. Ingrisch M., Sourbron S., Reiser M., Peller M. Model selection in dynamic contrast enhanced MRI: the Akaike information criterion. World Congr. Med. Phys. Biomed. Eng. 2010, 356-358. 10.1007/978-3-642-03882-2-94.
23. Ingrisch M., Sourbron S., Morhard D., Ertl-Wagner B., Ku T. Quantification of perfusion and permeability in multiple sclerosis. Investig. Radiol. 2012, 47:252-258.
24. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 5:143-156.
25. Larsson H.B.W., Frederiksen J., Kjær L., Henriksen O., Olesen J. In vivo determination ofT1 andT2 in the brain of patients with severe but stable multiple sclerosis. Magn. Reson. Med. 1988, 7:43-55. 10.1002/mrm.1910070106.
26. Larsson H.B.W., Courivaud F., Rostrup E., Hansen A.E. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn. Reson. Med. 2009, 62:1270-1281. 10.1002/mrm.22136.
27. Lavini C., Verhoeff J.J.C. Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn. Reson. Imaging 2010, 28:1420-1430. 10.1016/j.mri.2010.06.017.
28. Lowe M.J., Russell D.P. Treatment of baseline drifts in fMRI time series analysis. J. Comput. Assist. Tomogr. 1999, 23:463-473.
29. Luypaert R., Ingrisch M., Sourbron S., de Mey J. The Akaike information criterion in DCE-MRI: does it improve the haemodynamic parameter estimates?. Phys. Med. Biol. 2012, 57:3609-3628. 10.1088/0031-9155/57/11/3609.
30. Marstrand J.R., Garde E., Rostrup E., Ring P., Rosenbaum S., Mortensen E.L., Larsson H.B.W. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002, 33:972-976. 10.1161/01.STR.0000012808.81667.4B.
31. Montagne A., Barnes S.R., Law M., Zlokovic B.V., Montagne A., Barnes S.R., Sweeney M.D., Halliday M.R., Sagare A.P., Zhao Z., Toga A.W., Jacobs R.E., Liu C.Y., Amezcua L., Harrington M.G., Chui H.C. Blood-brain barrier breakdown in the aging human report blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015, 85:296-302. 10.1016/j.neuron.2014.12.032.
32. Parker G.J.M., Roberts C., Macdonald A., Buonaccorsi G.A., Cheung S., Buckley D.L., Jackson A., Watson Y., Davies K., Jayson G.C. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn. Reson. Med. 2006, 56:993-1000. 10.1002/mrm.21066.
33. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage 2011, 56:907-922. 10.1016/j.neuroimage.2011.02.046.
34. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 1983, 3:1-7.
35. Rohrer M., Bauer H., Mintorovitch J., Requardt M., Weinmann H.-J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Investig. Radiol. 2005, 40:715-724.
36. Sachdev P., Wen W., Shnier R., Brodaty H. Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast based perfusion MRI. J. Neuropsychiatry Clin. Neurosci. 2004, 16:83-92.
37. Schabel M.C., Parker D.L. Unscertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys. Med. Biol. 2010, 53:2345-2373. 10.1088/0031-9155/53/9/010.Uncertainty.
38. Schlageter K.E., Molnar P., Lapin G.D., Groothuis D.R. Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasc. Res. 1999, 58:312-328. 10.1006/mvre.1999.2188.
39. Shah N.J., Zaitsev M., Steinhoff S., Zilles K. A new method for fast multislice T(1) mapping. NeuroImage 2001, 14:1175-1185. 10.1006/nimg.2001.0886.
40. Smith S.M., Brady J.M. SUSAN-a new approach to low level image processing. Int. J. Comput. Vis. 1997, 23:45-78. 10.1023/A:1007963824710.
41. Sourbron S.P., Buckley D.L. On the scope and interpretation of the Tofts models for DCE-MRI. Magn. Reson. Med. 2011, 66:735-745. 10.1002/mrm.22861.
42. Sourbron S.P., Buckley D.L. Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Phys. Med. Biol. 2012, 57:R1-R33. 10.1088/0031-9155/57/2/R1.
43. Sourbron S.P., Buckley D.L. Classic models for dynamic contrast-enhanced MRI. NMR Biomed. 2013, 26:1004-1027. 10.1002/nbm.2940.
44. Sourbron S., Ingrisch M., Siefert A., Reiser M., Herrmann K. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn. Reson. Med. 2009, 62:205-217. 10.1002/mrm.22005.
45. Syková E., Nicholson C. Diffusion in brain extracellular space. Physiol. Rev. 2008, 88:1277-1340. 10.1152/physrev.00027.2007.
46. Taheri S., Gasparovic C., Huisa B.N., Adair J.C., Edmonds E., Prestopnik J., Grossetete M., Shah N.J., Wills J., Qualls C., Rosenberg G.A. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 2011, 42:2158-2163. 10.1161/STROKEAHA.110.611731.
47. Taheri S., Gasparovic C., Shah N.J., Rosenberg G.A. Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping. Magn. Reson. Med. 2011, 65:1036-1042. 10.1002/mrm.22686.
48. Thornhill R.E., Chen S., Rammo W., Mikulis D.J., Kassner A. Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation. Am. J. Neuroradiol. 2010, 31:1015-1022. 10.3174/ajnr.A2003.
49. Tofts P.S., Brix G., Buckley D.L., Evelhoch J.L., Henderson E., Knopp M.V., Larsson H.B.W., Lee T., Mayr N.A., Parker G.J.M., Port R.E., Taylor J., Weisskoff R.M. Contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 1999, 232:223-232.
50. Tomimoto H., Akiguchi I., Suenaga T., Nishimura M., Wakita H., Nakamura S., Kimura J. Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 1996, 27:2069-2074.
51. Topakian R., Barrick T.R., Howe F.A., Markus H.S. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J. Neurol. Neurosurg. Psychiatry 2010, 81:192-197. 10.1136/jnnp.2009.172072.
52. Valdés Hernández M.del C., Ferguson K.J., Chappell F.M., Wardlaw J.M. New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur. Radiol. 2010, 20:1684-1691. 10.1007/s00330-010-1718-6.
53. Vymazal J., Righini A., Brooks R.A., Canesi M., Mariani C., Leonardi M., Pezzoli G. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999, 211:489-495. 10.1148/radiology.211.2.r99ma53489.
54. Wahlund L.-O., Bronge L. Contrast-enhanced MRI of white matter lesions in patients with blood-brain barrier dysfunction. Ann. N. Y. Acad. Sci. 2000, 903:477-481.
55. Wardlaw J.M., Farrall A., Armitage P.A., Carpenter T., Chappell F., Doubal F., Chowdhury D., Cvoro V., Dennis M.S. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke 2008, 39:1327-1332. 10.1161/STROKEAHA.107.500124.
56. Wardlaw J.M., Smith C., Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013, 12:483-497. 10.1016/S1474-4422(13)70060-7.
57. Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R., Lindley R.I., O'Brien J.T., Barkhof F., Benavente O.R., Black S.E., Brayne C., Breteler M., Chabriat H., Decarli C., de Leeuw F.-E., Doubal F., Duering M., Fox N.C., Greenberg S., Hachinski V., Kilimann I., Mok V., van Oostenbrugge R., Pantoni L., Speck O., Stephan B.C.M., Teipel S., Viswanathan A., Werring D., Chen C., Smith C., van Buchem M., Norrving B., Gorelick P.B., Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013, 12:822-838. 10.1016/S1474-4422(13)70124-8.
58. Wharton S.B., Simpson J.E., Brayne C., Ince P.G. Age-associated white matter lesions: the MRC cognitive function and ageing study. Brain Pathol. 2015, 25:35-43. 10.1111/bpa.12219.
59. Young V.G., Halliday G.M., Kril J.J. Neuropathologic correlates of white matter hyperintensities. Neurology 2008, 71:804-811. 10.1212/01.wnl.0000319691.50117.54.